Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (871-880 of 1,142) with videos related to

Pageof 115
Sort By:
Schizophrenia Research|June 14, 2005
Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episodeStephen M Strakowski, Jacqueline L Johnson, Melissa P Delbello, et al.
Psychiatric Services (Washington, D.C.)|May 3, 2008
What CATIE found: results from the schizophrenia trialMarvin S Swartz, T Scott Stroup, Joseph P McEvoy, et al.
Schizophrenia Bulletin|January 1, 1992
Prospective study of psychobiology in first-episode schizophrenia at Hillside HospitalJ A Lieberman, J M Alvir, M Woerner, et al.
The American Journal of Psychiatry|July 4, 2007
Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparisonJoseph P McEvoy, Jeffrey A Lieberman, Diana O Perkins, et al.
Human Psychopharmacology|February 16, 2016
Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapineDanielle L Taylor, Arun K Tiwari, Jeffrey A Lieberman, et al.
Journal of Clinical Microbiology|August 18, 2021
High Clinical Impact of Broad-Range Fungal PCR in Suspected Fungal SinusitisJoshua A Lieberman, Andrew Bryan, James A Mays, et al.
Molecular Psychiatry|December 1, 1999
Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitizationK Yui, K Goto, S Ikemoto, et al.
Schizophrenia Research|September 6, 2011
The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine responseTristram A P Lett, Arun K Tiwari, Herbert Y Meltzer, et al.
The Journal of Clinical Psychiatry|September 1, 1994
Predictors of response to clozapineJ A Lieberman, J M Kane, A Z Safferman, et al.
Gut|December 15, 2015
Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysisSamir Gupta, Elizabeth T Jacobs, John A Baron, et al.
Pageof 115

Showing results (871-880 of 1,142) with videos related to

Sort By:
Pageof 115
Schizophrenia Research|June 14, 2005
Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episodeStephen M Strakowski, Jacqueline L Johnson, Melissa P Delbello, et al.
Psychiatric Services (Washington, D.C.)|May 3, 2008
What CATIE found: results from the schizophrenia trialMarvin S Swartz, T Scott Stroup, Joseph P McEvoy, et al.
Schizophrenia Bulletin|January 1, 1992
Prospective study of psychobiology in first-episode schizophrenia at Hillside HospitalJ A Lieberman, J M Alvir, M Woerner, et al.
The American Journal of Psychiatry|July 4, 2007
Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparisonJoseph P McEvoy, Jeffrey A Lieberman, Diana O Perkins, et al.
Human Psychopharmacology|February 16, 2016
Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapineDanielle L Taylor, Arun K Tiwari, Jeffrey A Lieberman, et al.
Journal of Clinical Microbiology|August 18, 2021
High Clinical Impact of Broad-Range Fungal PCR in Suspected Fungal SinusitisJoshua A Lieberman, Andrew Bryan, James A Mays, et al.
Molecular Psychiatry|December 1, 1999
Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitizationK Yui, K Goto, S Ikemoto, et al.
Schizophrenia Research|September 6, 2011
The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine responseTristram A P Lett, Arun K Tiwari, Herbert Y Meltzer, et al.
The Journal of Clinical Psychiatry|September 1, 1994
Predictors of response to clozapineJ A Lieberman, J M Kane, A Z Safferman, et al.
Gut|December 15, 2015
Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysisSamir Gupta, Elizabeth T Jacobs, John A Baron, et al.
Pageof 115